Clinical trials
Completed Inflammation trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
88 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 6 |
| 2022 | 9 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 88 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Universidad de Granada | 6 |
| Clinica Universidad de Navarra, Universidad de Navarra | 4 |
| Novo Nordisk A/S | 4 |
| Amgen | 3 |
| Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 3 |
| Instituto de Ciencia y Tecnología de Alimentos y Nutrición | 3 |
| AstraZeneca | 2 |
| Celia Bañuls | 2 |
| Fundació Eurecat | 2 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 88 |
| Obesity | 13 |
| Insulin Resistance | 6 |
| Metabolic Syndrome | 4 |
| Pulmonary Disease, Chronic Obstructive | 4 |
| Arthritis | 3 |
| Arthritis, Psoriatic | 3 |
| Arthritis, Rheumatoid | 3 |
| Asthma | 3 |
| Atherosclerosis | 3 |
Trials
Showing 1 to 25 of 88. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.